Terms: = Sarcomas AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Treatment
6 results:
1. Werner Syndrome Protein Expression in Breast Cancer.
Savva C; Sadiq M; Sheikh O; Karim S; Trivedi S; Green AR; Rakha EA; Madhusudan S; Arora A
Clin Breast Cancer; 2021 Feb; 21(1):57-73.e7. PubMed ID: 32919863
[TBL] [Abstract] [Full Text] [Related]
2. Decreased RECQL5 correlated with disease progression of osteosarcoma.
Wu J; Zhi L; Dai X; Cai Q; Ma W
Biochem Biophys Res Commun; 2015 Nov; 467(4):617-22. PubMed ID: 26499077
[TBL] [Abstract] [Full Text] [Related]
3. Targeting Werner syndrome protein sensitizes U-2 OS osteosarcoma cells to selenium-induced DNA damage response and necrotic death.
Cheng WH; Wu RT; Wu M; Rocourt CR; Carrillo JA; Song J; Bohr CT; Tzeng TJ
Biochem Biophys Res Commun; 2012 Mar; 420(1):24-8. PubMed ID: 22390926
[TBL] [Abstract] [Full Text] [Related]
4. The human wrn and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
Mao FJ; Sidorova JM; Lauper JM; Emond MJ; Monnat RJ
Cancer Res; 2010 Aug; 70(16):6548-55. PubMed ID: 20663905
[TBL] [Abstract] [Full Text] [Related]
5. wrn protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract] [Full Text] [Related]
6. [Werner's syndrome (adult onset progeria)].
Kluger N; Bessis D; Uhrhammer N; Guillot B; Aractingi S
Ann Dermatol Venereol; 2007 Feb; 134(2):140-2. PubMed ID: 17375009
[TBL] [Abstract] [Full Text] [Related]
